<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">8. Complications of LVADs</segment>
<segment id="2" parent="3" relname="concession">While survival has improved with CF-LVADS ,</segment>
<segment id="3" parent="1003" relname="span">the adverse event profile remains high .</segment>
<segment id="4" parent="1004" relname="span">At 1 month post-implant , nearly 30 % and at 1 year , almost 80 % of patients , require readmission .</segment>
<segment id="5" parent="4" relname="elaboration">The common LVAD-related complications , outside of the immediate post-operative period , are outlined in Table 4 .</segment>
<segment id="6" parent="1006" relname="span">Providers in the community may be the first medical contact for patients with LVADs</segment>
<segment id="7" parent="6" relname="elaboration">experiencing a complication .</segment>
<segment id="8" parent="9" relname="concession">Though management of these complications should be in concert with LVAD specialists ,</segment>
<segment id="9" parent="1008" relname="span">an awareness and understanding of the common complications can help with timely diagnosis and therapeutic intervention .</segment>
<segment id="10" parent="1011" relname="span">8.1. LVAD Infections</segment>
<segment id="11" parent="1012" relname="span">Due to the presence of a percutaneous driveline</segment>
<segment id="12" parent="1013" relname="span">exiting the skin ,</segment>
<segment id="13" parent="12" relname="elaboration">infections remain the Achilles heel of LVADs .</segment>
<segment id="14" parent="1014" relname="span">Recent implantation of the first-in-man totally implantable LVAD aims to minimize this risk .</segment>
<segment id="15" parent="1016" relname="span">ISHLT classifies infections in LVAD patients as VAD-specific</segment>
<segment id="16" parent="15" relname="elaboration">( involving the pump , cannula , pocket , or percutaneous driveline ) ,</segment>
<segment id="17" parent="1017" relname="span">VAD-related</segment>
<segment id="18" parent="1019" relname="span">( infective endocarditis , blood stream infections</segment>
<segment id="19" parent="18" relname="elaboration">including central venous catheter associated , mediastinitis )</segment>
<segment id="20" parent="1018" relname="joint">and non-VAD infections such as pneumonia .</segment>
<segment id="21" parent="1021" relname="same_unit">Different techniques , largely limited to single-center experiences ,</segment>
<segment id="22" parent="1022" relname="span">have been shown</segment>
<segment id="23" parent="1023" relname="joint">to reduce infection rates</segment>
<segment id="24" parent="1023" relname="joint">and there is no universal protocol .</segment>
<segment id="25" parent="1007" relname="joint">Risk factors for driveline infection include trauma to the driveline exit site , younger age , higher body mass index and exposed driveline velour .</segment>
<segment id="26" parent="1026" relname="span">Meticulous exit site and driveline care and driveline immobilization are advised</segment>
<segment id="27" parent="26" relname="purpose">to reduce the risk of infection .</segment>
<segment id="28" parent="1007" relname="joint">Driveline drainage culture and blood cultures should be obtained ,</segment>
<segment id="29" parent="1007" relname="joint">and imaging may be needed as well .</segment>
<segment id="30" parent="1032" relname="attribution">It is important to note</segment>
<segment id="31" parent="1033" relname="span">that driveline site assessment and obtaining specimens of the drainage should only be performed by members of the LVAD team</segment>
<segment id="32" parent="31" relname="elaboration">( or designated shared care centers )</segment>
<segment id="33" parent="1032" relname="same_unit">in order to limit the number of times and the number of people to whom the driveline is exposed .</segment>
<segment id="34" parent="1007" relname="joint">Culture of any drainage is recommended .</segment>
<segment id="35" parent="1035" relname="span">Abnormal swelling of the region surrounding the driveline site should be assessed by imaging studies</segment>
<segment id="36" parent="1036" relname="span">( i.e. , ultrasound , CT scan or PET scan )</segment>
<segment id="37" parent="36" relname="purpose">to assess the presence , extent , and appearance of any fluid collections .</segment>
<segment id="38" parent="1040" relname="span">Blood cultures are important</segment>
<segment id="39" parent="38" relname="purpose">to evaluate for occult bloodstream infections ,</segment>
<segment id="40" parent="1040" relname="cause">because LVAD patients may not present with typical signs and symptoms .</segment>
<segment id="41" parent="1041" relname="joint">Typical pathogens are skin flora like coagulase-negative Staphylococci and Staphylococcus aureus .</segment>
<segment id="42" parent="1042" relname="joint">Gram-negative organisms like Pseudomonas spp. and Enterobacteriaceae , and fungal infections can also occur .</segment>
<segment id="43" parent="1043" relname="span">Surgical evaluation for debridement of the driveline exit site may be needed</segment>
<segment id="44" parent="1044" relname="joint">depending on the extent of the infection ,</segment>
<segment id="45" parent="1045" relname="span">and should be performed by a surgical team with LVAD experience .</segment>
<segment id="46" parent="1046" relname="joint">Infectious diseases consultation may be needed , particularly in the case of polymicrobial infections or multidrug-resistant organisms .</segment>
<segment id="47" parent="1049" relname="condition">If bacteremia or sepsis are present ,</segment>
<segment id="48" parent="1050" relname="span">a chest and abdomen CT , transthoracic and even transesophageal echocardiogram should be obtained</segment>
<segment id="49" parent="48" relname="purpose">to evaluate for the source of the infection</segment>
<segment id="50" parent="1050" relname="elaboration">( especially in patients with pacemaker or defibrillator leads ) .</segment>
<segment id="51" parent="1051" relname="span">There is an emerging role for PET imaging with F-18 labeled fluoro-2-deoxyglucose .</segment>
<segment id="52" parent="1052" relname="span">VAD infections are biofilm-based and difficult to eradicate .</segment>
<segment id="53" parent="1054" relname="span">Treatment strategies for VAD infections include intravenous antibiotics</segment>
<segment id="54" parent="53" relname="elaboration">followed by oral suppression in tandem with surgical debridement .</segment>
<segment id="55" parent="1056" relname="span">Infections tend to be recurrent despite debridement ,</segment>
<segment id="56" parent="55" relname="elaboration">with Pseudomonas infection in particular , showing a lower success rate .</segment>
<segment id="57" parent="1057" relname="span">The role of pump exchange is not clearly defined .</segment>
<segment id="58" parent="1059" relname="joint">One study noted a particularly poor prognosis with candidemia and concomitant presence of a cardiac-implanted electronic device ,</segment>
<segment id="59" parent="1059" relname="joint">and failure to remove the device during pump exchange was associated with poor outcomes in 65 % of patients .</segment>
<segment id="60" parent="1062" relname="attribution">Some studies have shown</segment>
<segment id="61" parent="1062" relname="span">that LVAD infections adversely affect survival</segment>
<segment id="62" parent="61" relname="circumstance">after adjusting for age and comorbidities .</segment>
<segment id="63" parent="1064" relname="span">One prospective study showed a 22 % overall infection rate of LVADs and a 5.6-times greater 1-year mortality in patients with infections .</segment>
<segment id="64" parent="63" relname="elaboration">Besides mortality , LVAD infections are associated with a greater risk of pump thrombosis , bleeding complications , prolonged hospitalization , need for pump exchange , and failure to achieve transplantation .</segment>
<segment id="65" parent="1065" relname="span">Bloodstream infections , in particular , are associated with stroke and increased mortality .</segment>
<segment id="66" parent="67" relname="concession">Despite these risks ,</segment>
<segment id="67" parent="1067" relname="span">the presence of an LVAD infection has not been shown to have a negative impact on post-transplant outcomes .</segment>
<segment id="68" parent="1070" relname="span">8.2. Gastrointestinal</segment>
<segment id="69" parent="68" relname="restatement">( GI )</segment>
<segment id="70" parent="1069" relname="same_unit">Bleed</segment>
<segment id="71" parent="1071" relname="span">GI bleed is one of the most frequent complications after LVAD implant and the most common reason for hospital readmission .</segment>
<segment id="72" parent="1072" relname="span">It is triggered by the use of antiplatelet and anticoagulant therapy .</segment>
<segment id="73" parent="1073" relname="span">Additionally , CF-LVADs can cause acquired von Willebrand factor deficiency</segment>
<segment id="74" parent="1075" relname="span">due to the high shear stress</segment>
<segment id="75" parent="74" relname="elaboration">imposed by the LVAD motor ,</segment>
<segment id="76" parent="1075" relname="elaboration">resulting in breakdown of large von Willebrand factor multimers .</segment>
<segment id="77" parent="1076" relname="span">Also , continuous flow physiology and dysregulation of angiogenic factors have been shown to lead to development of arteriovenous malformations</segment>
<segment id="78" parent="77" relname="elaboration">( AVMs ) in the gastrointestinal tract , nasopharynx , brain , and other tissues .</segment>
<group id="1000" type="span" />
<group id="1001" type="multinuc" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="joint"/>
<group id="1003" type="span" parent="1002" relname="span"/>
<group id="1004" type="span" parent="1003" relname="elaboration"/>
<group id="1005" type="span" parent="1001" relname="joint"/>
<group id="1006" type="span" parent="1007" relname="preparation"/>
<group id="1007" type="multinuc" parent="1005" relname="span"/>
<group id="1008" type="span" parent="1007" relname="joint"/>
<group id="1011" type="span" parent="1007" relname="joint"/>
<group id="1012" type="span" parent="10" relname="cause"/>
<group id="1013" type="span" parent="11" relname="elaboration"/>
<group id="1014" type="span" parent="1007" relname="joint"/>
<group id="1015" type="multinuc" parent="14" relname="elaboration"/>
<group id="1016" type="span" parent="1015" relname="same_unit"/>
<group id="1017" type="span" parent="1015" relname="same_unit"/>
<group id="1018" type="multinuc" parent="17" relname="elaboration"/>
<group id="1019" type="span" parent="1018" relname="joint"/>
<group id="1021" type="multinuc" parent="1007" relname="joint"/>
<group id="1022" type="span" parent="1021" relname="same_unit"/>
<group id="1023" type="multinuc" parent="22" relname="purpose"/>
<group id="1026" type="span" parent="1007" relname="joint"/>
<group id="1031" type="span" parent="1007" relname="joint"/>
<group id="1032" type="multinuc" parent="1031" relname="span"/>
<group id="1033" type="span" parent="1032" relname="same_unit"/>
<group id="1035" type="span" parent="1007" relname="joint"/>
<group id="1036" type="span" parent="35" relname="elaboration"/>
<group id="1038" type="span" parent="1007" relname="joint"/>
<group id="1039" type="span" parent="1038" relname="span"/>
<group id="1040" type="span" parent="1039" relname="span"/>
<group id="1041" type="multinuc" parent="1039" relname="elaboration"/>
<group id="1042" type="multinuc" parent="1041" relname="joint"/>
<group id="1043" type="span" parent="1042" relname="joint"/>
<group id="1044" type="multinuc" parent="43" relname="elaboration"/>
<group id="1045" type="span" parent="1044" relname="joint"/>
<group id="1046" type="multinuc" parent="45" relname="elaboration"/>
<group id="1047" type="multinuc" parent="1046" relname="joint"/>
<group id="1048" type="span" parent="1047" relname="sequence"/>
<group id="1049" type="span" parent="1048" relname="span"/>
<group id="1050" type="span" parent="1049" relname="span"/>
<group id="1051" type="span" parent="1047" relname="sequence"/>
<group id="1052" type="span" parent="51" relname="elaboration"/>
<group id="1053" type="span" parent="52" relname="elaboration"/>
<group id="1054" type="span" parent="1053" relname="span"/>
<group id="1055" type="span" parent="1054" relname="elaboration"/>
<group id="1056" type="span" parent="1055" relname="span"/>
<group id="1057" type="span" parent="1056" relname="elaboration"/>
<group id="1058" type="span" parent="57" relname="elaboration"/>
<group id="1059" type="multinuc" parent="1058" relname="span"/>
<group id="1060" type="span" parent="1059" relname="elaboration"/>
<group id="1061" type="span" parent="1060" relname="span"/>
<group id="1062" type="span" parent="1061" relname="span"/>
<group id="1063" type="span" parent="1061" relname="elaboration"/>
<group id="1064" type="span" parent="1063" relname="span"/>
<group id="1065" type="span" parent="1064" relname="elaboration"/>
<group id="1066" type="span" parent="65" relname="elaboration"/>
<group id="1067" type="span" parent="1066" relname="span"/>
<group id="1068" type="span" parent="1067" relname="elaboration"/>
<group id="1069" type="multinuc" parent="1068" relname="span"/>
<group id="1070" type="span" parent="1069" relname="same_unit"/>
<group id="1071" type="span" parent="1069" relname="elaboration"/>
<group id="1072" type="span" parent="71" relname="elaboration"/>
<group id="1073" type="span" parent="72" relname="elaboration"/>
<group id="1074" type="span" parent="73" relname="cause"/>
<group id="1075" type="span" parent="1074" relname="span"/>
<group id="1076" type="span" parent="1007" relname="joint"/>
	</body>
</rst>
